Xcerra Corp. (NASDAQ:XCRA)’s share price traded up 1.8% during mid-day trading on Friday . The stock traded as high as $6.13 and last traded at $6.08, with a volume of 141,683 shares traded. The stock had previously closed at $5.97.

Several equities analysts have recently issued reports on the company. B. Riley reaffirmed a “buy” rating and issued a $8.25 price target on shares of Xcerra Corp. in a research report on Tuesday, June 7th. Needham & Company LLC reaffirmed a “hold” rating on shares of Xcerra Corp. in a research report on Tuesday, June 7th. Finally, Zacks Investment Research lowered Xcerra Corp. from a “hold” rating to a “sell” rating in a research report on Wednesday, August 10th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating to the stock. Xcerra Corp. currently has an average rating of “Hold” and a consensus target price of $8.69.

The firm has a 50-day moving average price of $5.94 and a 200 day moving average price of $5.95. The firm has a market capitalization of $325.43 million and a price-to-earnings ratio of 28.68.

In other Xcerra Corp. news, VP Pascal Ronde sold 30,000 shares of the company’s stock in a transaction on Thursday, June 9th. The stock was sold at an average price of $6.63, for a total value of $198,900.00. Following the transaction, the vice president now owns 221,250 shares of the company’s stock, valued at approximately $1,466,887.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Xcerra Corporation, formerly LTX-Credence Corporation, is engaged in providing test and handling capital equipment, interface products, test fixtures and related services to the semiconductor and electronics manufacturing industries. The Company operates through six segments: Semiconductor Test, Semiconductor Handlers, Contactors, Printed Circuit Board (PCB) Test, Probes/Pins and Fixtures.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.